PTPN22 and type 1 diabetes mellitus: Reduction of Lck, Lat, Zap70 and Prdm1 expression in T cells and a SNP mutation in Ptpn22 have been associated with rheumatoid arthritis, systemic lupus erythematosus and T1D in humans17,18,45–47.